Thrombin has biphasic effects on the nitric oxide-cGMP pathway in endothelial cells and contributes to experimental pulmonary hypertension.
BACKGROUND: A potential role for coagulation factors in pulmonary arterial hypertension has been recently described, but the mechanism of action is currently not known. Here, we investigated the interactions between thrombin and the nitric oxide-cGMP pathway in pulmonary endothelial cells and experi...
Main Authors: | Katrin F Nickel, Volker Laux, Rolf Heumann, Georges von Degenfeld |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3681801?pdf=render |
Similar Items
-
Targeting L-arginine-nitric oxide-cGMP pathway in pulmonary arterial hypertension
by: Haiyang Tang, et al.
Published: (2017-09-01) -
cGMP-independent nitric oxide signaling and regulation of the cell cycle
by: Cintron Ana, et al.
Published: (2005-11-01) -
Characterization of novel rhodopsins with light-regulated cGMP production or cGMP degradation
by: Tian, Yuehui
Published: (2019) -
Studies on Characterization and Tissue Distribution of cGMP-binding cGMP-specific Phosphodiesterase
by: Kotera, Jun
Published: (2014) -
Nitric oxide-mediated cGMP signal transduction in the central nervous system
by: Bartus, K.
Published: (2010)